We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

[NEW DELHI] A researcher from Johns Hopkins University in Baltimore is among those accused of unethical conduct in a clinical trial carried out in India. The scandal has emerged barely a week after clinical trials at Johns Hopkins University were temporarily suspended following the death of a volunteer in a drug trial.

The high court in the state of Kerala has accepted a petition claiming that an investigational drug was injected into cancer patients at the Regional Cancer Centre (RCC) in Thiruvananthapuram, the state capital, without clearance from the Drug Controller General of India, and without approval from the institutional ethical committee.

The chief minister of Kerala, Arakkal Parambil Kurien Antony, last week ordered an investigation into the clinical trial.

Reference: Nature 412, 466 (2001)

Link to full text

Related topics